Drugs for postmenopausal osteoporosis.  [electronic resource] 

 -  Treatment guidelines from the Medical Letter  Oct 2008 
 - 67-74; quiz 75-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1541-2784 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized<br/>Bone Density Conservation Agents--adverse effects<br/>Calcitonin--adverse effects<br/>Calcium--therapeutic use<br/>Denosumab<br/>Diphosphonates--adverse effects<br/>Drug Combinations<br/>Estrogens--adverse effects<br/>Female<br/>Humans<br/>Nonprescription Drugs--adverse effects<br/>Osteoporosis, Postmenopausal--drug therapy<br/>Parathyroid Hormone--adverse effects<br/>Practice Guidelines as Topic<br/>Prescription Drugs--adverse effects<br/>RANK Ligand--adverse effects<br/>Randomized Controlled Trials as Topic<br/>Vitamin D--therapeutic use